109 related articles for article (PubMed ID: 28383563)
1. Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.
Han J; Xie C; Pei T; Wang J; Lan Y; Huang K; Cui Y; Wang F; Zhang J; Pan S; Liang Y; Zhen T; Song R; Sun B; Li Y; Shi H; Yang G; Liu X; Zhu M; Wang Y; Li K; Liu Y; Meng F; Liao F; Meng X; Hong X; Liu L
Cell Death Dis; 2017 Apr; 8(4):e2736. PubMed ID: 28383563
[TBL] [Abstract][Full Text] [Related]
2. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
[TBL] [Abstract][Full Text] [Related]
3. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway.
Li LY; Yang JF; Rong F; Luo ZP; Hu S; Fang H; Wu Y; Yao R; Kong WH; Feng XW; Chen BJ; Li J; Xu T
Acta Pharmacol Sin; 2021 Oct; 42(10):1676-1689. PubMed ID: 33514855
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
[TBL] [Abstract][Full Text] [Related]
5. The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO-Mediated Nuclear Export of ZEB1 mRNA.
Hou YR; Diao LT; Hu YX; Zhang QQ; Lv G; Tao S; Xu WY; Xie SJ; Zhang Q; Xiao ZD
Adv Sci (Weinh); 2023 Aug; 10(23):e2301983. PubMed ID: 37271897
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC.
Sreekumar R; Emaduddin M; Al-Saihati H; Moutasim K; Chan J; Spampinato M; Bhome R; Yuen HM; Mescoli C; Vitale A; Cillo U; Rugge M; Primrose J; Hilal MA; Thirdborough S; Tulchinsky E; Thomas G; Mirnezami A; Sayan AE
Cell Death Dis; 2019 Sep; 10(10):703. PubMed ID: 31543517
[TBL] [Abstract][Full Text] [Related]
7. ZEB1 Fuels Serine Metabolism to Promote HCC Metastasis.
Chan FF; Wong CM
Cell Mol Gastroenterol Hepatol; 2023; 16(4):646-647. PubMed ID: 37517803
[No Abstract] [Full Text] [Related]
8. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
Mao X; Zhou L; Tey SK; Ma APY; Yeung CLS; Ng TH; Wong SWK; Liu BHM; Fung YME; Patz EF; Cao P; Gao Y; Yam JWP
J Extracell Vesicles; 2020 Nov; 10(1):e12031. PubMed ID: 33708358
[TBL] [Abstract][Full Text] [Related]
9. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1.
Yan YL; Huang ZN; Zhu Z; Cui YY; Li MQ; Huang RM; Yan J; Shen B
Front Oncol; 2020; 10():667. PubMed ID: 32528872
[TBL] [Abstract][Full Text] [Related]
11. AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
Di C; Mladkova N; Lin J; Fee B; Rivas M; Chunsheng K; Bigner D; Adamson DC
Int J Oncol; 2018 Jan; 52(1):47-54. PubMed ID: 29115565
[TBL] [Abstract][Full Text] [Related]
12. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
Qu W; Wen X; Su K; Gou W
J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
[TBL] [Abstract][Full Text] [Related]
13. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
[TBL] [Abstract][Full Text] [Related]
14. Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells.
Hötte K; Smyrek I; Starzinski-Powitz A; Stelzer EHK
Biol Open; 2017 Jun; 6(6):723-731. PubMed ID: 28483980
[TBL] [Abstract][Full Text] [Related]
15. Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1.
Yang L; Liu J; Li S; Liu X; Zheng F; Xu S; Fu B; Xiong J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9787-9804. PubMed ID: 37247081
[TBL] [Abstract][Full Text] [Related]
16. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
17. Current Approaches in Surgical and Immunotherapy-Based Management of Renal Cell Carcinoma with Tumor Thrombus.
Tabbara MM; González J; Martucci M; Ciancio G
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672712
[TBL] [Abstract][Full Text] [Related]
18. MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization.
Pasapera AM; Heissler SM; Eto M; Nishimura Y; Fischer RS; Thiam HR; Waterman CM
Curr Biol; 2022 Jun; 32(12):2704-2718.e6. PubMed ID: 35594862
[TBL] [Abstract][Full Text] [Related]
19. Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing.
Shi Y; Zhang Q; Bi H; Lu M; Tan Y; Zou D; Ge L; Chen Z; Liu C; Ci W; Ma L
Genome Biol; 2022 Mar; 23(1):87. PubMed ID: 35361264
[TBL] [Abstract][Full Text] [Related]
20. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
Palmeri M; Mehnert J; Silk AW; Jabbour SK; Ganesan S; Popli P; Riedlinger G; Stephenson R; de Meritens AB; Leiser A; Mayer T; Chan N; Spencer K; Girda E; Malhotra J; Chan T; Subbiah V; Groisberg R
ESMO Open; 2022 Feb; 7(1):100336. PubMed ID: 34953399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
